Related Experiment Videos
Is topical metronidazole effective in seborrheic dermatitis? A double-blind study
Rafet Koca1, H Cevdet Altinyazar, Emel Eştürk
1Department of Dermatology, Faculty of Medicine, Zonguldak Karaelmas University, Zonguldak, Turkey. rafetkoca@karaelmas.edu.tr
International Journal of Dermatology
|August 2, 2003
Summary
Metronidazole 0.75% gel showed similar efficacy to placebo for treating facial seborrheic dermatitis in a clinical trial. Further research may be needed to explore alternative treatments for this common skin condition.
Area of Science:
- Dermatology
- Clinical Research
- Pharmacology
Background:
- Seborrheic dermatitis is a prevalent, chronic skin condition requiring frequent treatment.
- Current therapeutic options often necessitate repeated treatment courses.
Purpose of the Study:
- To evaluate the efficacy of metronidazole 0.75% gel versus placebo.
- The study focused on patients with mild to moderate facial seborrheic dermatitis.
- A randomized, double-blind, placebo-controlled design was employed.
Main Methods:
- Eighty-four patients with facial seborrheic dermatitis were enrolled.
- Participants applied either metronidazole 0.75% gel or a placebo twice daily for 8 weeks.
- Lesion severity was assessed bi-weekly, with a final evaluation at study completion.
Main Results:
- No statistically significant difference in lesion severity reduction was observed between the metronidazole and placebo groups.
- Patient-reported outcomes at 8 weeks also showed no significant difference between treatments.
- Metronidazole 0.75% gel was well-tolerated by participants.
Conclusions:
- Metronidazole 0.75% gel and placebo demonstrated comparable efficacy in managing facial seborrheic dermatitis.
- The findings suggest metronidazole gel may not offer a significant advantage over placebo for this condition.